# India Personalized Medicine Market > India Personalized Medicine Market Research Report By Product Outlook (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application Outlook (Oncology, CNS, Immunology, Respiratory, Others) and By End-User Outlook (Hospitals, Diagnostic Centers, Research Academic Institutes, Others) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.41% - **2024:** $ 37.29 Billion - **2025:** $ 39.68 Billion - **2035:** $ 73.88 Billion - **Key Players:** Roche (CH), Thermo Fisher Scientific (US), Illumina (US), Novartis (CH), GSK (GB), Bristol-Myers Squibb (US), Pfizer (US), Merck KGaA (DE), Amgen (US) **Report ID:** MRFR/HC/43636-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-personalized-medicine-market-45316 --- ## Market Summary ## **India Personalized Medicine Market Overview** As per MRFR analysis, the India Personalized Medicine Market Size was estimated at 27.83 (USD Billion) in 2023.The India Personalized Medicine Market is expected to grow from 29.84(USD Billion) in 2024 to 80.0 (USD Billion) by 2035. The India Personalized Medicine Market CAGR (growth rate) is expected to be around 9.381% during the forecast period (2025-2035). **Key India Personalized Medicine Market Trends Highlighted** The market for personalized medicine in India is undergoing revolutionary changes due to developments in biotechnology and genomics. The expanding understanding of the significance of customizing therapies to each patient's unique genetic profile, which results in more efficient healthcare solutions, is driving the increased acceptance of precision medicine. In order to improve the field of customized medicine, the Indian government has taken the initiative to support biotechnology research and development and to build partnerships between the public and commercial sectors. This dedication is demonstrated by the National Biotechnology Development Strategy, which establishes India as a center for healthcare innovation. The accuracy of disease detection and treatment routes is being improved by recent trends showing an increase in the demand for molecular diagnostics and genetic testing in India. Telemedicine and mobile health platforms are helping patients, especially those in rural and semi-urban regions, receive individualized medicine as a result of the strong push toward digital health solutions. Additionally, new potential for patient data analysis, treatment method improvement, and result prediction are being made possible by the integration of big data and artificial intelligence in healthcare systems. This industry offers a lot of potential, particularly in areas where the prevalence of chronic illnesses like diabetes and cancer is high. In these areas, personalized medicine can have a significant impact on patient outcomes and management. Innovation in tailored therapeutics depends on the continuous partnerships between Indian healthcare providers and research organizations. The potential to use this trend to create individualized treatment regimens is clear as patients and healthcare professionals become more aware of customized medicine. For the personalized medicine market in India to flourish as the healthcare environment changes, regulatory issues must be resolved, and infrastructure must be improved. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India Personalized Medicine Market Drivers** **Increasing Prevalence of Chronic Diseases** The rising incidence of chronic diseases, particularly cancer, cardiovascular diseases, and diabetes, is significantly boosting the growth of the India Personalized Medicine Market. According to the National Institute of Cancer Prevention and Research, the number of cancer cases in India is expected to rise from 14 lakh in 2020 to an estimated 29 lakh by 2040. This continuous increase puts pressure on the healthcare system and drives the demand for personalized medicine strategies that target the unique genetic make-up of patients for more effective treatment. Organizations like the Tata Memorial Centre are at the forefront, utilizing personalized medicine approaches for treating cancer, thereby impacting treatment outcomes and pushing for innovations within the industry. As the number of patients requiring tailored therapies increases, the viability and attractiveness of the India Personalized Medicine Market grow, making it a focal area for investment and development. **Advancements in Genomic Research** The rapid advancements in genomic research and technology are propelling the India Personalized Medicine Market. With a growing number of genomic sequencing projects, such as the Indian Genome Variation project, which has mapped the genetic variation across diverse Indian populations, there's an increasing pool of data available for developing customized treatments. The Indian government has been supportive of this by funding various genomic medicine initiatives, which has led to a pronounced rise in precision medicine applications in healthcare. According to recent data from the Department of Biotechnology, the sector could see a surge in companies leveraging genomic data for developing medications, which reinforces the impact on personalized medicine strategies. **Supportive Government Initiatives and Policies** The Indian government's proactive initiatives to promote healthcare innovation directly impact the India Personalized Medicine Market. For instance, the 'National Health Mission' and 'Ayushman Bharat' schemes emphasize advancements in healthcare technology and affordable treatment for all. Supported by the Biotechnology Industry Research Assistance Council (BIRAC), these initiatives aim to foster growth in the biotech and personalized medicine sector. With more than 500 biotech startups emerging in India due to policies promoting research and development, the government is creating a conducive environment for personalized medicine to thrive, thus significantly boosting the industry's prospects in personalized therapeutics. **Growing Awareness and Acceptance of Personalized Medicine** There is an increasing awareness and acceptance of personalized medicine among healthcare professionals and patients in India. Educational campaigns led by organizations like the Indian Medical Association have been effective in disseminating knowledge about the benefits of targeted therapies and precision medicine. According to surveys, approximately 70% of healthcare providers in urban areas are now recognizing the importance of personalized treatment plans, illustrating a shift in treatment paradigms. This cultural shift is crucial as it drives demand for personalized medical solutions, leading to heightened growth within the India Personalized Medicine Market. The increasing willingness of patients to engage in therapies tailored to their individual genetic profiles indicates a growing trust in the capabilities of personalized medicine. **India Personalized Medicine Market Segment Insights** **Personalized Medicine Market Product Outlook Insights** The India Personalized Medicine Market offers a diverse range of products that meet the evolving healthcare needs of the population, particularly through its Product Outlook segment. This segment includes critical pathways such as Personalized Medicine Diagnostics, which plays a vital role in early disease detection and tailored treatment strategies for patients. Personalized Medicine Therapeutics focuses on improving treatment efficacy by utilizing genetic and molecular insights, thereby personalizing drug responses and minimizing adverse effectsa necessity in a diverse nation like India with its varied genetic profiles. Furthermore, Personalized Medical Care emphasizes the holistic approach to patient management, targeting both physical and mental health tailored to individual conditions and lifestyle choices. In addition, Personalized Nutrition and Wellness addresses the growing awareness of health optimization through customized dietary recommendations, which resonate strongly with the increasing health-conscious segment of the Indian population. This growing interest reflects a broader trend toward preventive healthcare, highlighting the importance of personalized solutions in addressing chronic disease management and enhancing overall wellness. Overall, these interconnected areas are shaped by advancements in technology, increasing healthcare access, and rising consumer awareness, which collectively drive innovation and growth within the India Personalized Medicine Market, creating a substantial opportunity for stakeholders in the healthcare ecosystem. The market dynamics are further influenced by government initiatives aimed at promoting personalized healthcare solutions, aligning with broader health objectives to improve outcomes for a diverse demographic, thereby showcasing the evident growth and potential across these critical product areas. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Personalized Medicine Market Application Outlook Insights** The India Personalized Medicine Market within the Application Outlook segment is experiencing robust growth, driven by advancements in technology and increased healthcare spending. The oncology segment holds a significant share, as personalized therapies are increasingly recognized for their effectiveness in targeting cancer, which is a leading cause of mortality in India. The growing prevalence of chronic diseases further emphasizes the need for tailored treatment approaches. Central Nervous System (CNS) disorders also present substantial opportunities, given the rising incidence of mental health issues and neurodegenerative diseases. Immunology is expanding as precision medicine plays a pivotal role in managing autoimmune diseases and enhancing vaccine efficacy, which is particularly relevant given India's diverse genetic landscape. The respiratory segment is gaining attention due to the alarming air quality issues in many cities, and personalized treatments are critical for effectively managing conditions such as asthma and COPD. Lastly, the "Others" category encompasses various innovative applications, indicating the versatility of personalized medicine in addressing different healthcare needs. Overall, the segmentation within the India Personalized Medicine Market highlights a dynamic landscape with significant opportunities for enhancing patient outcomes through tailored therapies. **Personalized Medicine Market End-User Outlook Insights** The India Personalized Medicine Market is significantly influenced by various end-user segments, including Hospitals, Diagnostic Centers, Research Academic Institutes, and Others. Hospitals serve as a critical hub for personalized medicine, leveraging advanced technologies to tailor treatments to individual patient profiles, ensuring better outcomes and higher patient satisfaction. Similarly, Diagnostic Centers play a vital role by enabling precise diagnostics, which is foundational in the development of personalized treatments, making them essential to this evolving market landscape. Research Academic Institutes are at the forefront of innovation in personalized medicine, driving breakthroughs through extensive studies and trials. These institutions collaborate with industry players to enhance the overall understanding and application of personalized therapies. Other end-users also contribute to the market dynamics, including specialty clinics and home healthcare services, creating a diverse ecosystem that supports the growing demand for personalized medicine solutions. The growing population and increasing prevalence of chronic diseases in India are substantial growth drivers for these segments, while challenges such as regulatory hurdles and high costs of personalized therapies present opportunities for major innovations within the market. The India Personalized Medicine Market segmentation underscores the need for tailored approaches in healthcare, aligning seamlessly with the nation's push towards advanced medical solutions. **India Personalized Medicine Market Key Players and Competitive Insights** The India Personalized Medicine Market is rapidly evolving, driven by advancements in genomics, biotechnology, and healthcare technology. As healthcare shifts from a one-size-fits-all approach to more individualized treatment options, the competitive landscape of this market is becoming increasingly dynamic. Several companies are vying for market share, focusing on innovative solutions tailored to specific patient needs. The competition is characterized by a blend of established pharmaceutical giants and emerging biotech firms, all seeking to capitalize on the growing demand for personalized treatments. Given the vast diversity in the Indian population and the associated health challenges, firms are continuously investing in research and development to refine their offerings. Collaboration with academic institutions and healthcare providers is also a strategy employed to stay ahead in this competitive race, ensuring that products are not only scientifically validated but also meet the regulatory standards set forth by health authorities. Myntra, while primarily known as an e-commerce platform, is diversifying its portfolio to include various lifestyle and health initiatives, thereby entering the realm of personalized medicine within India. The company boasts strengths in its extensive customer base and data analytics capabilities, utilizing consumer insights to inform and personalize health-related product offerings. With a strong focus on enhancing user experience through technology, Myntra has the potential to connect personalized medicine solutions to a broader audience, tapping into existing data to recommend tailored health products. Additionally, the company's supply chain and logistics capabilities enable it to efficiently deliver specialized health products, reinforcing its competitive edge in this emerging market. Biocon stands out in the India Personalized Medicine Market as a major player focusing on biopharmaceutical innovations. Known for its robust portfolio of biotech products, Biocon places a significant emphasis on providing affordable biosimilars that cater to personalized treatment protocols for chronic diseases. The company's key offerings include monoclonal antibodies and recombinant proteins, which are pivotal in the delivery of targeted therapies. Biocon has established a strong market presence through various strategic collaborations and alliances with global companies, tapping into broader synergies for drug development. Moreover, its recent mergers and acquisitions have strengthened its capabilities and expanded its reach in the personalized medicine domain. This strategic positioning, coupled with consistent investment in research and development, has enabled Biocon to cater to the unique healthcare needs of the Indian population, bolstering its reputation as a leader in biopharmaceutical innovations in the personalized medicine sector. **Key Companies in the India Personalized Medicine Market Include** - Myntra - Biocon - Syngene International - Dr. Lal PathLabs - HealthCare Global Enterprises - Mylab Discovery Solutions - Genes2Me - Cellix Bio - MedGenome - Nalanda Diagnostics - Mapmygenome - Egenes - Strand Life Sciences - Omicsx - Qure.ai **India Personalized Medicine****Market****Developments** Recent developments in the India Personalized Medicine Market highlight significant advancements and strategic movements among key players. In October 2023, Biocon announced a collaboration with a leading biotechnology firm to develop next-generation biosimilars, aiming to enhance patient outcomes through personalized therapies. HealthCare Global Enterprises launched a personalized cancer care program to tailor treatment plans based on genetic profiles, reflecting the urgent need for precision in oncology. In September 2023, Mylab Discovery Solutions expanded its offerings with new diagnostic tests focusing on genetic markers, showcasing a trend toward integrating genomics with routine clinical practice. Additionally, Dr. Lal PathLabs reported a partnership with the government to extend genetic testing capabilities across rural areas, enhancing accessibility. Furthermore, Strand Life Sciences and MedGenome are actively involved in developing AI-driven diagnostic solutions, indicating a growing intersection of technology and personalized medicine. Over the past two years, numerous companies have seen significant market valuation growth due to these innovations, reflecting an increasing recognition of the importance of personalized treatments in India's healthcare landscape. The government's push for improved healthcare infrastructure also supports this burgeoning market, underscoring its vital role in future medical advancements. **India Personalized Medicine Market Segmentation Insights** **Personalized Medicine Market****Product****Outlook** **Personalized Medicine Market****Application****Outlook** **Personalized Medicine Market****End-User****Outlook** -   -   -   -   -   - Beta Beta feature ## Market Drivers ### Increasing Healthcare Expenditure The rising healthcare expenditure in India is a crucial driver for the personalized medicine market. As the government and private sectors allocate more funds towards healthcare, the demand for advanced medical solutions, including personalized therapies, is likely to increase. In 2025, healthcare spending in India is projected to reach approximately $370 billion, reflecting a growth rate of around 12% annually. This financial commitment enables the development and accessibility of personalized medicine, which is tailored to individual patient needs. Furthermore, as healthcare costs rise, patients are increasingly seeking effective treatments that minimize adverse effects and enhance outcomes. This trend indicates a shift towards personalized approaches, thereby propelling the personalized medicine market forward. ### Regulatory Support for Innovation Regulatory support for innovation in the healthcare sector is a vital driver for the personalized medicine market. The Indian government has implemented various policies aimed at promoting research and development in personalized therapies. Initiatives such as the Biotechnology Industry Research Assistance Council (BIRAC) provide funding and support for startups and established companies focusing on personalized medicine. This regulatory framework encourages innovation and facilitates the entry of new products into the market. As a result, the personalized medicine market is likely to benefit from a more conducive environment for research and development, leading to the introduction of novel therapies that cater to individual patient needs. ### Advancements in Biotech and Pharma Advancements in biotechnology and pharmaceutical research are pivotal in shaping the personalized medicine market. India has witnessed a surge in biotech firms focusing on innovative therapies tailored to individual patient profiles. The Indian biotech industry is expected to reach $100 billion by 2025, with a significant portion dedicated to personalized medicine. These advancements enable the development of targeted therapies that are more effective and have fewer side effects compared to traditional treatments. Moreover, collaborations between research institutions and pharmaceutical companies are fostering innovation in drug development. This synergy is likely to enhance the availability of personalized medicine options, thereby driving market growth. ### Growing Awareness of Genetic Testing The growing awareness of genetic testing among the Indian population is significantly influencing the personalized medicine market. As individuals become more informed about the benefits of genetic testing, there is an increasing demand for personalized therapies that cater to specific genetic profiles. In recent years, the market for genetic testing in India has expanded, with estimates suggesting a growth rate of over 15% annually. This awareness is driven by educational campaigns and the increasing availability of genetic testing services. Consequently, healthcare providers are more inclined to offer personalized treatment options based on genetic insights, which enhances patient outcomes and satisfaction. This trend is likely to continue, further stimulating the personalized medicine market. ### Rising Incidence of Chronic Diseases The rising incidence of chronic diseases in India is a significant driver for the personalized medicine market. With conditions such as diabetes, cancer, and cardiovascular diseases becoming increasingly prevalent, there is a growing need for tailored treatment approaches. Reports indicate that chronic diseases account for nearly 60% of all deaths in India, highlighting the urgent need for effective management strategies. Personalized medicine offers the potential for targeted therapies that can improve patient outcomes and reduce healthcare costs. As the healthcare system shifts towards more individualized care, the personalized medicine market is expected to expand, addressing the unique needs of patients suffering from chronic conditions. ## Future Outlook The [Personalized Medicine Market](https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937) in India is projected to grow at a 6.41% CAGR from 2025 to 2035, driven by advancements in genomics, technology integration, and increasing healthcare demand. **New opportunities:** - Development of AI-driven diagnostic tools for personalized treatment plans. - Expansion of telemedicine platforms for remote genetic consultations. - Investment in biobanks for personalized drug development and research. By 2035, The Personalized Medicine Market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Personalized Medicine Diagnostics (Largest) vs. Personalized Medicine Therapeutics (Fastest-Growing) The India personalized medicine market exhibits a diverse landscape in the product segment, with Personalized Medicine Diagnostics holding a significant share due to its pivotal role in precision medicine. This segment encompasses various diagnostic tools and technologies that are integral to understanding patient-specific responses to treatment, thereby enhancing treatment outcomes. Following closely, Personalized Medicine Therapeutics is witnessing remarkable growth, attributed to an increasing focus on tailored therapies for chronic diseases, pushing the boundaries of traditional treatment models. Several factors contribute to the growth trends in this segment, including advancements in genomic technologies and a rising awareness among healthcare providers and patients about personalized approaches. The surge in chronic diseases and the demand for more effective treatments are steering investments towards innovations in personalized therapeutics. Additionally, increased government support and funding for personalized medicine initiatives are nurturing a favorable ecosystem for emerging therapies, making this segment one of the most exciting areas within the market. Personalized Medicine Diagnostics (Dominant) vs. Personalized Nutrition and Wellness (Emerging) Personalized Medicine Diagnostics stands as the dominant force within the India personalized medicine market, driven by technological advancements and a growing emphasis on disease prevention and early detection. This segment includes genetic testing, biomarker identification, and other diagnostic tools designed to tailor treatments to individual patient profiles. Conversely, Personalized Nutrition and Wellness is emerging as a new frontier, focusing on dietary solutions tailored to an individual's genetic makeup and lifestyle choices. This segment is gaining traction as consumers increasingly prioritize health and well-being, making informed dietary choices based on personalized data. While Diagnostics remains critical for immediate healthcare applications, Nutrition and Wellness taps into a preventive approach, making both segments essential to a comprehensive personalized medicine strategy. ### By Application: Oncology (Largest) vs. CNS (Fastest-Growing) In the India personalized medicine market, Oncology accounts for the largest share among the application segments, driven by the increasing incidence of cancer and the demand for targeted therapies. CNS therapies follow with a notable share, reflecting the growing recognition of neurological disorders. Other segments like Immunology and Respiratory also contribute but at a smaller scale, highlighting a diverse application landscape that caters to various medical needs. Growth trends indicate a significant rise in the demand for personalized approaches, particularly in Oncology and CNS. Factors such as technological advancements in genomics, increased healthcare expenditure, and a shift towards patient-centric care are propelling the growth of these segments. The expansion of healthcare infrastructure and rising awareness about personalized medicine further enhance the market potential for both dominant and emerging applications. Oncology (Dominant) vs. CNS (Emerging) Oncology remains the dominant application segment in the market, renowned for its extensive research and development activities that focus on personalized therapies, which are tailored to individual genetic profiles. This segment benefits from substantial investment in biotechnology and pharmaceutical developments aimed at improving patient outcomes. In contrast, CNS represents an emerging application, characterized by rapid innovations in treatment strategies for disorders such as Alzheimer's and Parkinson's. The growing prevalence of neurological diseases, coupled with advancements in diagnostics and therapeutic interventions, positions CNS as a vital segment poised for growth, reflecting the evolving landscape of personalized medicine. ### By End-User: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing) In the India personalized medicine market, hospitals hold the largest market share, characterized by their extensive infrastructure and resources dedicated to personalized treatments. This segment accounts for a significant portion of the overall market due to the increasing adoption of personalized medicine initiatives and advanced technologies in patient care. In contrast, diagnostic centers are witnessing rapid growth, driven by the rising demand for precise diagnostics and personalized therapies that enhance treatment outcomes. Growth trends indicate a robust shift towards personalized medicine in hospitals, focusing on tailored therapies that cater to individual patient needs. The growth of diagnostic centers is fueled by advancements in genetic testing and biomarker identification, which are critical for personalized treatment plans. Additionally, increased partnerships between hospitals and diagnostic centers are enhancing service offerings, promoting patient-centric care, and encouraging a collaborative approach to personalized medicine delivery. Hospitals (Dominant) vs. Diagnostic Centers (Emerging) Hospitals are the dominant players in the personalized medicine segment, leveraging their extensive patient base and advanced technological capabilities to provide tailored treatments. Their ability to integrate personalized approaches into patient care models positions them as leaders in the market. Conversely, diagnostic centers are emerging as vital contributors, focusing on innovative testing methodologies that support personalized medicine. Their agility in adopting new technologies and expanding their services makes them essential in the personalized healthcare landscape. The synergy between hospitals and diagnostic centers is crucial for evolving patient care, with both segments complementing each other's strengths to enhance treatment accuracy and effectiveness. ## Competitive Benchmarking The personalized medicine market in India is currently characterized by a dynamic competitive landscape, driven by rapid advancements in genomics, biotechnology, and data analytics. Key players such as Roche (CH), Thermo Fisher Scientific (US), and Illumina (US) are at the forefront, leveraging their innovative capabilities to enhance patient outcomes. Roche (CH) focuses on integrating diagnostics with therapeutics, thereby creating a seamless approach to personalized treatment. Meanwhile, Thermo Fisher Scientific (US) emphasizes its commitment to expanding its product portfolio through strategic partnerships and acquisitions, which enhances its market presence. Illumina (US) continues to lead in genomic sequencing technologies, positioning itself as a critical player in the development of personalized therapies. Collectively, these strategies foster a competitive environment that prioritizes innovation and patient-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive technological advancements. This competitive structure allows for a diverse range of offerings, catering to the unique needs of the Indian healthcare landscape. In October Roche (CH) announced a collaboration with a leading Indian biotechnology firm to develop targeted therapies for oncology patients. This strategic partnership is expected to accelerate the development of personalized treatment options, leveraging local expertise and resources. The collaboration underscores Roche's commitment to enhancing its footprint in the Indian market while addressing the specific needs of the population. In September Thermo Fisher Scientific (US) launched a new suite of genomic analysis tools tailored for the Indian market. This launch is significant as it aims to empower local researchers and clinicians with advanced technologies that facilitate personalized medicine initiatives. By providing accessible and cutting-edge tools, Thermo Fisher is likely to strengthen its position and foster innovation within the region. In August Illumina (US) expanded its partnership with Indian healthcare institutions to enhance genomic research capabilities. This initiative is pivotal as it not only broadens access to genomic data but also promotes collaboration between academia and industry. Such partnerships are essential for driving advancements in personalized medicine and ensuring that the latest technologies are effectively utilized in clinical settings. As of November current trends in the personalized medicine market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Companies are likely to differentiate themselves through innovative solutions that enhance patient care, suggesting a future where personalized medicine becomes more accessible and effective. ## Recent News & Developments Recent developments in the India Personalized Medicine Market highlight significant advancements and strategic movements among key players. In October 2023, Biocon announced a collaboration with a leading biotechnology firm to develop next-generation biosimilars, aiming to enhance patient outcomes through personalized therapies. HealthCare Global Enterprises launched a personalized cancer care program to tailor treatment plans based on genetic profiles, reflecting the urgent need for precision in oncology. In September 2023, Mylab Discovery Solutions expanded its offerings with new diagnostic tests focusing on genetic markers, showcasing a trend toward integrating genomics with routine clinical practice. Additionally, Dr. Lal PathLabs reported a partnership with the government to extend genetic testing capabilities across rural areas, enhancing accessibility. Furthermore, Strand Life Sciences and MedGenome are actively involved in developing AI-driven diagnostic solutions, indicating a growing intersection of technology and personalized medicine. Over the past two years, numerous companies have seen significant market valuation growth due to these innovations, reflecting an increasing recognition of the importance of personalized treatments in India's healthcare landscape. The government's push for improved healthcare infrastructure also supports this burgeoning market, underscoring its vital role in future medical advancements. ## Report Scope | MARKET SIZE 2024 | 37.29(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 39.68(USD Billion) | | MARKET SIZE 2035 | 73.88(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.41% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Roche (CH), Thermo Fisher Scientific (US), Illumina (US), Novartis (CH), GSK (GB), Bristol-Myers Squibb (US), Pfizer (US), Merck KGaA (DE), Amgen (US) | | Segments Covered | Product, Application, End-User | | Key Market Opportunities | Integration of artificial intelligence in personalized medicine enhances treatment precision and patient outcomes. | | Key Market Dynamics | Rising demand for targeted therapies drives innovation and competition in the personalized medicine market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the personalized medicine market in India?** A: The overall market valuation was $37.29 Billion in 2024. **Q: What is the projected market size for personalized medicine in India by 2035?** A: The projected valuation for 2035 is $73.88 Billion. **Q: What is the expected CAGR for the personalized medicine market in India from 2025 to 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 6.41%. **Q: Which companies are the key players in the personalized medicine market in India?** A: Key players include Roche, Thermo Fisher Scientific, Illumina, Novartis, GSK, Bristol-Myers Squibb, Pfizer, Merck KGaA, and Amgen. **Q: What are the main segments of the personalized medicine market in India?** A: Main segments include Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition and Wellness. **Q: How much is the Personalized Medicine Therapeutics segment valued at in 2024?** A: The Personalized Medicine Therapeutics segment was valued at $15.0 Billion in 2024 and is projected to reach $30.0 Billion. **Q: What is the valuation of the Oncology application segment in the personalized medicine market?** A: The Oncology application segment was valued at $15.0 Billion in 2024 and is expected to grow to $30.0 Billion. **Q: Which end-user segment has the highest valuation in the personalized medicine market?** A: The Hospitals end-user segment was valued at $12.0 Billion in 2024 and is projected to reach $24.0 Billion. **Q: What is the projected growth for the Personalized Nutrition and Wellness segment?** A: The Personalized Nutrition and Wellness segment was valued at $7.29 Billion in 2024 and is expected to grow to $13.88 Billion. **Q: How does the growth of the personalized medicine market in India compare to other regions?** A: While specific comparisons to other regions are not provided, the projected growth rate of 6.41% suggests a robust expansion in the Indian market. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-personalized-medicine-market-45316*